Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia: results from the CEPHEUS study in Arabian Gulf countries.

Arafah M, Al-Hinai AT, Al Mahmeed W, Al-Rasadi K, Al Tamimi O, Al Herz S, Al Anazi F, Al Nemer K, Metwally O, Alkhadra A, Fakhry M, Elghetany H, Medani AR, Yusufali AH, Al Jassim O, Al Hallaq O, Baslaib FO, Alawadhi M, Amin H, Al-Hashmi K, Shehab A.

Angiology. 2014 Nov;65(10):919-26. doi: 10.1177/0003319713512414. Epub 2013 Dec 3.

PMID:
24301426
2.

Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece survey.

Elisaf MS, Nikas N.

Angiology. 2010 Jul;61(5):465-74. doi: 10.1177/0003319710366432. Epub 2010 May 12.

PMID:
20462896
3.

Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS).

Chiang CE, Ferrières J, Gotcheva NN, Raal FJ, Shehab A, Sung J, Henriksson KM, Hermans MP.

J Atheroscler Thromb. 2016 May 2;23(5):567-87. doi: 10.5551/jat.31179. Epub 2015 Dec 2.

4.

Therapeutic lipid target achievements among high and highest risk patients: results from the CEPHEUS study in the Arabian Gulf.

Al-Rasadi K, Al-Zakwani I, Al Mahmeed W, Arafah M, Al-Hinai AT, Shehab A, Al Tamimi O, Alawadhi M.

Curr Med Res Opin. 2014 Dec;30(12):2429-35. doi: 10.1185/03007995.2014.965774. Epub 2014 Sep 29.

PMID:
25222765
5.

Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.

Park JE, Chiang CE, Munawar M, Pham GK, Sukonthasarn A, Aquino AR, Khoo KL, Chan HW.

Eur J Prev Cardiol. 2012 Aug;19(4):781-94. doi: 10.1177/1741826710397100. Epub 2011 Mar 7.

PMID:
21450606
6.

Achieving low-density lipoprotein cholesterol treatment goals among dyslipidemic individuals in the Levant: the CEntralized Pan-Levant survey on tHE Undertreatment of hypercholeSterolemia (CEPHEUS) study.

Hammoudeh AJ, Echtay A, Ghanem GY, Haddad J; CEPHEUS-Levant survey investigators.

Curr Med Res Opin. 2014 Oct;30(10):1957-65. doi: 10.1185/03007995.2014.929095. Epub 2014 Jun 18.

PMID:
24889279
7.

Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey.

Wang KF, Chang CC, Wang KL, Wu CH, Chen LC, Lu TM, Lin SJ, Chiang CE.

J Chin Med Assoc. 2014 Feb;77(2):61-7. doi: 10.1016/j.jcma.2013.10.013. Epub 2013 Dec 11.

8.

CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia.

Raal F, Schamroth C, Blom D, Marx J, Rajput M, Haus M, Hussain R, Cassim F, Nortjé M, Vandehoven G, Temmerman AM.

Cardiovasc J Afr. 2011 Sep-Oct;22(5):234-40. doi: 10.5830/CVJA-2011-044. Epub 2011 Sep 15.

10.

Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.

Sukonthasarn A, Homsanit M, Prommete B, Chotinaiwattarakul C, Piamsomboon C, Likittanasombat K.

J Med Assoc Thai. 2011 Dec;94(12):1424-34.

PMID:
22295727
11.

Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian Gulf.

Al-Hashmi K, Al-Zakwani I, Al Mahmeed W, Arafah M, Al-Hinai AT, Shehab A, Al Tamimi O, Al Awadhi M, Al Herz S, Al Anazi F, Al Nemer K, Metwally O, Alkhadra A, Fakhry M, Elghetany H, Medani AR, Yusufali AH, Al Jassim O, Al Hallaq O, Baslaib FO, Amin H, Santos RD, Al-Waili K, Al-Rasadi K.

J Clin Lipidol. 2016 Mar-Apr;10(2):368-77. doi: 10.1016/j.jacl.2015.12.021. Epub 2015 Dec 23.

12.

Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries.

Hermans MP, Castro Cabezas M, Strandberg T, Ferrières J, Feely J, Elisaf M, Michel G, Sansoy V.

Curr Med Res Opin. 2010 Feb;26(2):445-54. doi: 10.1185/03007990903500565.

PMID:
20001658
13.

The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.

Chan RH, Chan PH, Chan KK, Lam SC, Hai JJ, Wong MK, Tam FC, Lam L, Chan CW, Lam YM, Siu DC, Tse HF, Lee SW.

Hong Kong Med J. 2012 Oct;18(5):395-406.

14.

Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.

Waters DD, Brotons C, Chiang CW, Ferrières J, Foody J, Jukema JW, Santos RD, Verdejo J, Messig M, McPherson R, Seung KB, Tarasenko L; Lipid Treatment Assessment Project 2 Investigators.

Circulation. 2009 Jul 7;120(1):28-34. doi: 10.1161/CIRCULATIONAHA.108.838466. Epub 2009 Jun 22.

15.

Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study.

Kim HS, Wu Y, Lin SJ, Deerochanawong C, Zambahari R, Zhao L, Zhang Q, Yan P.

Curr Med Res Opin. 2008 Jul;24(7):1951-63. doi: 10.1185/03007990802138731 . Epub 2008 Jun 10.

PMID:
18547466
16.

Assessment of lipid-lowering treatment in France--the CEPHEUS study.

Ferrières J, Gousse ET, Fabry C, Hermans MP; French CEPHEUS Investigators.

Arch Cardiovasc Dis. 2008 Sep;101(9):557-63. doi: 10.1016/j.acvd.2008.08.006. Epub 2008 Oct 11.

17.

[Pan-European survey on the undertreatment of hypercholesterolemia in hypolipidemias(Luxembourg)].

Michel G, Muller P.

Bull Soc Sci Med Grand Duche Luxemb. 2008;(4):509-16. French.

PMID:
19024370
18.

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.

Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.

Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C.

PMID:
12646338
19.

Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).

Wong ND, Chuang J, Wong K, Pham A, Neff D, Marrett E.

Am J Cardiol. 2013 Aug 1;112(3):373-9. doi: 10.1016/j.amjcard.2013.03.041. Epub 2013 Apr 30.

PMID:
23642513
20.

[Lipid lowering goals in high risk and very high cardiovascular risk patients: a reasonable challenge?].

Gómez-Belda A, Rodilla E, González C, Costa JA, Serra B, Pascual JM.

Rev Clin Esp. 2006 Oct;206(9):417-21. Spanish.

PMID:
17042982

Supplemental Content

Support Center